Human Molecular Genetics

Part 1: Basics of DNA, Chromosomes, Cells, Development and Inheritance. 1. Basic Principles of Nucleic Acid Structure and Gene Expression. 2. Fundamentals of Cells and Chromosomes. 3. Fundamentals of Cell-Cell Interactions and Immune System Biology. 4. Aspects of Early Mammalian Development, Cell Differentiation, and Stem Cells. 5. Patterns of Inheritance. Part 2: Understanding Genomes. 6. Core DNA Technologies: Amplifying DNA, Nucleic Acid Hybridization, and DNA Sequencing. 7. Analyzing the Structure and Expression of Genes and Genomes. 8. Principles of Genetic Manipulation of Mammalian Cells. 9. Uncovering the Architecture and Workings of the Human Genome. 10. Gene Regulation and the Epigenome. Part 3: Genetic Variation between Individuals and Species. 11. An Overview of Human Genetic Variation. 12. Human Population Genetics. 13. Comparative Genomics and Genome Evolution. 14. Human Evolution. Part 4: Human Genetic Disease. 15. Chromosomal Abnormalities and Structural Variants. 16. Molecular Pathology: Connecting Phenotypes to Genotypes. 17. Mapping and Identifying Genes for Monogenic Disorders. 18. Complex Disease: Identifying Susceptibility Factors and Understanding Pathogenesis. 19. Cancer Genetics and Genomics. Part 5: Applied Human Molecular Genetics. 20. Genetic Testing in Healthcare and the Law. 21. Model Organisms and Modeling Disease. 22. Genetic Approaches to Treating Disease.

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Genética (não médica)
• Biologia molecular
• Biologia Celular (citologia)

DNA Sequence;DNA Molecule;genetics;DNA Strand;molecular biology;DNA Clone;nucleic acid;DNA;Genome Editing;RNA;SNP Chip;polypeptide;Germ Line DNA;structure;DNA Methylation;DNA structure;MHC Protein;RNA structure;DNA Fragment;double helix;Junk DNA;nucleotide;Chromosomal DNA;base pair;DNA Replication;complementary;T-cell Receptor;antiparallel;TCRs;replication;Grow DNA Strand;semiconservative;Pluripotent Stem Cell;semidiscontinuous;DNA Content;polymerase;Stem Cell;leading strand;Exome Sequencing;lagging strand;Genome Wide Association Studies;proofreading;Haplotype Blocks;virus;DSB;genome;ESCs;processing;splicing;transcript;transcription;gene;gene expression;sense;antisense;promoter;enhancer;messenger RNA;ribosomal RNA;transfer RNA;translation;genetic code;degeneration;modification;protein;noncoding RNA;purine;pyrimidine;amino acid;intron;exon;snRNP;untranslated;codon;anticodon;universal;chemical modification;medicine;techniques;chromosome;chromosome structure;chromosome function;ploidy;cell cycle;mitosis;meiosis;cell division;gamete;diploid;haploid;independent assortment;interphase chromosome;chromatin;centromere;telomere;linear chromosome;chromosome analysis;staining;banding;cytogenetics;FISH;painting;karyotyping;comparative genomic hybridization;mixoploidy;misrepair;development;zygote;somatic;chromatid;bivalent;replication origin;heterochromatin;spindle;probe;chromosome break;parental origin;nondisjunction;pedigree;inheritance;multifactorial;Mendelian;X-inactivation;mosaicism;Y chromosome;bias;character;locus heterogeneity;clinical heterogeneity;pedigree pattern;recessive;dominant;late onset;imprinting;male lethality;inbreeding;heritability;threshold model;dichotomous;counseling;Hardy-Weinberg;mutation rate;allele;phenotype;hemizygous;susceptibility;quantitative trait loci;segregation ratio;complementation test;congenital;coefficient of selection;founder effect;Barr body;coefficient of inbreeding;coefficient of relationship;emperic risk;epistasis;lyonization;one gene-one enzyme;cell junctions;extracellular matrix;synapse;programmed cell death;embryonic stem cell;pluripotent;second messenger;necrosis;totipotent;ES Cell;allelic exlusion;model organism;specialization;pattern formation;polarization;germ layers;sex determination;positional information;homeobox;morphogen;endoderm;blastocyst;restriction endonuclease;ligase;large insert cloning;extrachromosomal;low copy number;bacterial artificial chromosome;yeast artificial chromosome;megabase fragments;phagemid;cloning system;baculovirus;marker gene;screening;heteroduplex;oligonucleotide;radioisotopes;fluorophores;dot-blot;Southern blot;northern blot;ISH;Affymetrix;Illumina;autoradiography;nonisotpoic;fluorescence;electrophoresis;genomic library;library screening;dideoxy sequencing;iterative pyrosequencing;massively parallel sequencing;physical map;immunoblotting;global gene expression;transcript profiling;mass spectrometry;transcriptome;restriction fragment length polymorphism;mitochrondrial genome;copy number variation;overlapping gene;gene superfamily;pseudogene;short interfering RNA;Piwi-protein-interaction RNA;constitutive heterochromatin;high copy number;retrotransposon;high-throughput screening;fitness;predicted gene;dosage;pseudoautosomal;phylogenetic tree;bootstrapping;human-specific;methylation;paramutation;transgenerational;alternative promoter;DNase-hypersensitive site;functional genomics;consensus sequence;sequence comparison;knockout;protein-protein interaction;yeast two hybrid screening;immunoprecipitation;mapping interactions;interspersed repeat;short tandem repeat polymorphism;forensic;fragile site;complementation group;missense;splice site;gain-of-function;haploinsufficiency;phenotypic effect;compound heterozygote;chance effect;chiasma;two-point mapping;whole genome;three-point crosses;ancestral haplotype;centimorgan;crossover;phase-known;polymorphism information content;twin studies;identity by state;sib pair analysis;association studies;odds ratio;tag-SNP;transmission disequilibrium;wide association studies;affected sib pairs anaysis;concordance;candidate region;chromosomal abnormality;causal variant;HapMap;complex disease;microcell-mediated chromosome transfer;retinoblastoma;two-hit paradigm;loss of heterozygosity;cell cycle control;single-strand conformation analysis;protein truncation test;pyrosequencing;whole exon deletion;whole exon duplication;aneuploidy;triplet repeat disease;DNA fingerprinting;ethics;pharmacongenomics;personalized medicine;population screening;clinical validity;clinical utility;pharmacokinetics;pharmacodynamics;phase 2 metabolism;drug target;depersonalized medicine;polypill;microinjection;nuclear transfer;site-specific recombination;chromosome engineering;zinc finger nucleases;insertional mutagenesis;mouse;International Mouse Knockout Consortium;leaky mutation;chromosome disorder;Cre-loxP;Morpholino;mAb;tissue stem cell;induced pluripotent stem cell;transdifferentiation;augumentation;adenoviral vector;adeno-associated viral vector;naked nucleic acid;lipid-mediated gene transfer;nanoparticle;siRNA;exon skipping;blood cell disoder;Andrew Read;DNA sequencing technologies;disease modeling;cell biology;human genetic disease;RNA genomes;DNA rReplication;Human molecular genetics